<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01517490</url>
  </required_header>
  <id_info>
    <org_study_id>Klefter1</org_study_id>
    <nct_id>NCT01517490</nct_id>
  </id_info>
  <brief_title>Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes</brief_title>
  <official_title>Retinal Adaptation to Intensified Insulin Therapy and Bariatric Surgery in Patients With Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retinal function is highly dependent on the glucose supply. Thus, functional adaptations
      occur in response to both acute and long-term changes in glycaemia.

      The purpose of this study is to examine functional and metabolic aspects of retinal
      adaptation to long-lasting changes in glycaemic control in patients with diabetes. The
      adaptational phenomena will be characterized by electroretinography, dark adaptation,
      measures of retinal perfusion and oximetry as well as diabetic retinopathy grading and (OCT).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2011</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in dark adaptation kinetics and threshold values, amplitudes/implicit times, retinal vessel diameters, perfusion velocity and oximetry.</measure>
    <time_frame>Baseline, 1 week, 1 month, 4 months, 7 months, 12 months, 18 months, 24 months, 42 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in visual acuity, diabetic retinopathy grading and OCT</measure>
    <time_frame>Baseline, 1 week, 1 month, 4 months, 7 months, 12 months, 18 months, 24 months, 42 months</time_frame>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Diabetic Retinopathy</condition>
  <arm_group>
    <arm_group_label>Type 1 Insulin Pump</arm_group_label>
    <description>Patients with type 1 diabetes starting insulin pump treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 1 conventional therapy</arm_group_label>
    <description>Patients with type 1 diabetes continuing treatment with multiple daily insulin injections.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 Bariatric surgery</arm_group_label>
    <description>Patients with type 2 diabetes who are enrolled in pre-operative weight loss protocol prior to bariatric surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 conventional</arm_group_label>
    <description>Severely obese patients with type 2 diabetes who are to continue with non-surgical treatments of diabetes and obesity and with no planned bariatric surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 1 insulin pumpe follow-up</arm_group_label>
    <description>Patients with type 1 diabetes previously followed in an observational study with electrophysiological and psychophysical measures of retinal function.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy volunteers.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Insulin pump</intervention_name>
    <description>Insulin pump therapy</description>
    <arm_group_label>Type 1 Insulin Pump</arm_group_label>
    <arm_group_label>Type 1 insulin pumpe follow-up</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multiple daily insulin injections</intervention_name>
    <description>Multiple daily insulin injections</description>
    <arm_group_label>Type 1 conventional therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bariatric surgery</intervention_name>
    <description>Pre-operative weight loss and bariatric surgery.</description>
    <arm_group_label>Type 2 Bariatric surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medical therapy for type 2 diabetes</intervention_name>
    <description>Medical glucose-lowering therapy and non-surgical weight-lowering interventions.</description>
    <arm_group_label>Type 2 conventional</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        30 patients with type 1 diabetes and suboptimal metabolic regulation which is to be
        optimized by insulin pump therapy.

        30 patients with type 1 diabetes and suboptimal metabolic regulation in whom insulin pump
        therapy is not planned.

        20 patients with type 2 diabetes and suboptimal metabolic regulation who are enrolled in a
        pre-operative weight lowering protocol prior to bariatric surgery.

        20 patients with type 2 diabetes and suboptimal metabolic regulation who are not enrolled
        in treatment protocols relating to bariatric surgery.

        17 patients with type 1 diabetes on insulin pump therapy who were previously followed in an
        observational study of retinal function.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with type 1 diabetes and suboptimal metabolic regulation.

          -  Patients with type 2 diabetes and suboptimal metabolic regulation.

        Exclusion Criteria:

          -  Significant cataract

          -  Glaucoma

          -  Proliferative diabetic retinopathy fulfilling ETDRS treatment criteria.

          -  Clinically significant macular edema fulfilling ETDRS treatment criteria.

          -  Age-related macular degeneration

          -  Prior surgery to the eye

          -  Other serious eye disease

          -  Hypertension
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Klefter, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup UH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Larsen, Professor, DMSci</last_name>
    <role>Study Director</role>
    <affiliation>Glostrup UH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Oliver Klefter, MD</last_name>
    <phone>+45 38 63 48 18</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Ophthalmology, Glostrup Hospital</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Klefter, MD</last_name>
      <phone>+45 38 63 48 18</phone>
      <email>oliver.niels@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Michael Larsen, Professor, DMSci</last_name>
      <phone>+45 38 63 48 34</phone>
    </contact_backup>
    <investigator>
      <last_name>Oliver Klefter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Larsen, Professor, DMSci</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2012</study_first_submitted>
  <study_first_submitted_qc>January 24, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2012</study_first_posted>
  <last_update_submitted>March 10, 2015</last_update_submitted>
  <last_update_submitted_qc>March 10, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Oliver Niels Klefter</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

